학술논문

Seroprevalence of Lyme disease in Eastern Slovakia.
Document Type
Journal Article
Source
Central European Journal of Public Health. 2018 Supplement, pS67-S71. 5p.
Subject
*LYME disease
*SEROPREVALENCE
*RECOMBINANT proteins
*TICK-borne encephalitis viruses
*SYNOVIAL fluid
*BORRELIA burgdorferi
*LYME disease diagnosis
*ANIMALS
*ENZYME-linked immunosorbent assay
*EPIDEMIOLOGICAL research
*GRAM-negative bacteria
*IMMUNOGLOBULINS
*VIRAL antibodies
*DISEASE incidence
*CROSS-sectional method
*BACTERIAL antibodies
Language
ISSN
1210-7778
Abstract
Objective: Lyme disease (LD) is chronic, multi-system zoonosis transmitted by ticks, and LD aetiological agents are spirochetes of the Borrelia burgdorferi sensu lato complex. The aim of the cross-sectional study was to analyze the LD incidence on the basis of the presence of specific antibodies in the serum of patients in Eastern Slovakia, and to compare the results of serological ELISA and immunoblot assays.Methods: Venous blood with questionnaires was obtained by field sampling of respondents from Eastern Slovakia. Overall, we examined 537 human sera by the ELISA and for confirmation we tested all positive IgG antibodies against the Borrelia immunoblot assay.Results: Our results confirmed the high serum prevalence of anti-Borrelia antibodies (17.9% for IgG), while the immunoblot seropositive test was confirmed in 69.8% of responders from ELISA IgG positive sera. Positive antibodies of the IgM class were found in 7.6% of the population under study. Most commonly found were antibodies against VlsE (80.2%), p41 (66.7%), p18 (56.3%), p100 (41.7%), p58 (31.3%), and p39 (30.2%).Conclusion: It should be noted that detection of antibodies against B. burgdorferi s.l. is only an indirect evidence of the presence of this bacterium in the development of clinical signs of LD in humans. Laboratory LD tests should be performed in accordance with valid standards, positive and uncertain results must be confirmed by the Western Blot/Immunoblot assay. [ABSTRACT FROM AUTHOR]